REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 84 filers reported holding REGULUS THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $7,243,000 | -76.2% | 1,045,119 | -70.0% | 0.93% | -69.2% |
| Q4 2015 | $30,371,000 | +15.0% | 3,482,924 | -13.8% | 3.00% | -20.8% |
| Q3 2015 | $26,420,000 | -36.4% | 4,039,823 | +6.6% | 3.79% | -9.2% |
| Q2 2015 | $41,544,000 | -31.7% | 3,790,476 | +5.6% | 4.18% | -30.8% |
| Q1 2015 | $60,826,000 | -20.0% | 3,590,688 | -24.3% | 6.04% | -26.1% |
| Q4 2014 | $76,076,000 | – | 4,742,911 | – | 8.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |